You are here

Warfarin Pharmacogenomics

Jiayi Li, MD; Shan Wang, PharmD, RPh; Joseph Barone, PharmD Candidate; and Brian Malone, MS, RPh
PDF version: 
Warfarin is commonly used to prevent and treat thromboembolic disease, but it is difficult to administer at the correct dose, primarily because of variations in patient responses. With new advances in medicine, it may be possible to tailor pharmacotherapy based on a patient’s genetic profile.